532167 — Omkar Pharmachem Balance Sheet
0.000.00%
- IN₹57.07m
- IN₹54.90m
- IN₹4.65m
Annual balance sheet for Omkar Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.11 | 1.33 | 0.716 | 1.09 | 2.17 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.81 | 1.3 | 1.13 | 1.56 | 0.834 |
| Total Other Current Assets | |||||
| Total Current Assets | 2.92 | 2.62 | 1.84 | 2.65 | 3.01 |
| Net Property, Plant And Equipment | 0.064 | 0.037 | 0.065 | 0.058 | 0.029 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 98.3 | 97.3 | 95.9 | 96 | 367 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.84 | 6.86 | 3.6 | 1.7 | 0.506 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.84 | 6.86 | 3.6 | 1.7 | 0.506 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 88.5 | 90.4 | 92.3 | 94.3 | 366 |
| Total Liabilities & Shareholders' Equity | 98.3 | 97.3 | 95.9 | 96 | 367 |
| Total Common Shares Outstanding |